Benjamin Jacob Samelson-Jones, MD, PhD
Assistant Professor of Pediatrics (Hematology) at the Children's Hospital of Philadelphia
Assistant Professor, Perelman School of Medicine at the University of Pennsylvania
Member, The Raymond G. Perelman Center for Cellular and Molecular Therapeutics (CCMT), University of Pennsylvania School of Medicine
Associate Director, Clinical In Vivo Gene Therapy, Children's Hospital of Philadelphia
Department: Pediatrics
Graduate Group Affiliations
Contact information
Children's Hospital of Philadelphia
Colket Translational Research Building, Rm 5028
3501 Civic Center Blvd
Philadelphia, PA 19104
Colket Translational Research Building, Rm 5028
3501 Civic Center Blvd
Philadelphia, PA 19104
Office: 267-425-0147
Fax: 215-590-3660
Fax: 215-590-3660
Publications
Education:
AB (Physics )
Amherst College, 2001.
MS (Biological Sciences)
Albert Einstein College of Medicine, 2006.
PhD (Biophysics)
Albert Einstein College of Medicine, 2009.
MD
Albert Einstein College of Medicine, 2009.
Permanent linkAB (Physics )
Amherst College, 2001.
MS (Biological Sciences)
Albert Einstein College of Medicine, 2006.
PhD (Biophysics)
Albert Einstein College of Medicine, 2009.
MD
Albert Einstein College of Medicine, 2009.
Selected Publications
Valentino LA, Ozelo MC, Herzog RW, Key NS, Pishko AM, Ragni MV, Samelson-Jones BJ, Lillicrap D.: A Review of the Rationale for Gene Therapy for Hemophilia A With Inhibitors: One-Shot Tolerance and Treatment? J Thromb Haemost May 2023.Samelson-Jones BJ, George LA: Adeno-associated Viral Gene Therapy for Hemophilia. Annu. Rev. Med Page: 231-247, Jan 2023.
Samelson-Jones, BJ: A New Harmony for Hemorrhagic Disorders: The Dutch SYMPHONY Consortium J Thromb Haemost 20(9): 1984-1985, Sep 2022.
Samelson-Jones BJ.: Worldwide use of factor IX Padua for hemophilia B gene therapy. Mol Ther 30(3): 2394-2396, Jul 2022.
Padua H, Cahill AM, Chewning R, Himes E, Kukreja K, Kumar R, Marshalleck F, Monroe E, Patel S, Samelson-Jones BJ, Shaikh R, : Appendix to Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions: Pediatric Considerations. J Vasc Interv Radiol 1: S1051-0443, Jul 2022.
Takasaki K, Hehir D, Raffini L, Samelson-Jones BJ, Shih E, Dain AS.: Andexanet alfa for reversal of rivaroxaban in a child with intracranial hemorrhage. Pediatr Blood Cancer 69(6): e29484, Jun 2022.
Takasaki K, Hehir D, Raffini , Samelson-Jones B, Shih E, Dain AS : Andexanet alfa for reversal of rivaroxaban in a child with intracranial hemorrhage. Pediatr Blood Cancer 69(6): e29484, Jun 2022.
Mejia EJ, O'Connor MJ, Samelson-Jones BJ, Mavroudis CD, Giglia TM, Keashen R, Rossano J, Naim MY, Maeda K.: Successful treatment of intracardiac thrombosis in the presence of fulminant myocarditis requiring ECMO associated with COVID-19. J Heart Lung Transplant 41(6): 849-851, Jun 2022.
Chen R, Muralidharan K, Samelson-Jones BJ.: Digital haemophilia: Insights into the use of social media for haemophilia care, research and advocacy. Haemophilia 28(2): 247-253, Mar 2022.
Lee K, Chau JQ, Sternberg AR, Pishko AM, George L, Samelson-Jones BJ.: Factor VIII Mimetic Rescue of Hemophilia B Causing Factor IX Variants. Blood 2022.